CN105198935A - Chiral oxazoline palladium coordination compound - Google Patents

Chiral oxazoline palladium coordination compound Download PDF

Info

Publication number
CN105198935A
CN105198935A CN201510636902.9A CN201510636902A CN105198935A CN 105198935 A CN105198935 A CN 105198935A CN 201510636902 A CN201510636902 A CN 201510636902A CN 105198935 A CN105198935 A CN 105198935A
Authority
CN
China
Prior art keywords
oxazoline
reaction
coordination compound
chlorobenzene
chiral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510636902.9A
Other languages
Chinese (zh)
Inventor
罗梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hefei Xiangchen Chemical Engineering Co Ltd
Original Assignee
Hefei Xiangchen Chemical Engineering Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hefei Xiangchen Chemical Engineering Co Ltd filed Critical Hefei Xiangchen Chemical Engineering Co Ltd
Priority to CN201510636902.9A priority Critical patent/CN105198935A/en
Publication of CN105198935A publication Critical patent/CN105198935A/en
Pending legal-status Critical Current

Links

Landscapes

  • Catalysts (AREA)

Abstract

The invention discloses a chiral oxazoline palladium coordination compound. A chemical formula of the chiral oxazoline palladium coordination compound is shown in the specification. A synthetic method of the chiral oxazoline palladium coordination compound includes: adding 5.5782g of o-dicyanobenzene and 19.2782g of D- phenylalaninol into a chlorobenzene solvent to realize a reflux reaction for 60 hours under a water-free oxygen-free condition with ZnCl2 (23.8mol%) serving as a catalyst, and then separating and purifying, namely removing chlorobenzene after reaction, using chloroform for extraction after water addition for dissolution, and adopting column chromatography for purification after desolvation of an extract phase; using petroleum ether and dichloromethane (4:1) for elution, carrying out column chromatography separation to obtain ligand oxazoline after natural volatilization; adding chiral ligand oxazoline and palladium chloride in the chlorobenzene solvent according to a mole ratio of 1:1.0 to realize the reflux reaction for 48 hours, removing chlorobenzene after reaction to obtain red brown solid, adding trichloromethane and ethanol solution for filtering, and allowing filtrate to volatilize naturally to obtain red brown single crystals of the oxazoline palladium coordination compound. The chiral oxazoline palladium coordination compound has a catalytic function in benzaldehyde Henry reaction and allylic alkylation reaction with conversion rates being 85% and 68% respectively.

Description

A kind of chiral oxazoline palladium complex
one, technical field
The present invention relates to a kind of organometallic complex (title complex) and uses thereof, particularly nitrogenous chiral metal organic coordination compound and purposes, is exactly a kind of chiral oxazoline metallic palladium organic coordination compound and uses thereof.
two, background technology
Along with vitochemical development, the application of organometallics in organic synthesis is more and more wide, is one of field of very enlivening in present organic chemistry, has been widely used in organic synthesis.The asymmetric catalysis synthesis of the use chiral ligand that the later stage sixties 20th century occurs and transition metal complex catalysis accelerates the research of chiral drug greatly.The important content of chemical catalysis dissymmetric synthesis is the design of chiral ligand and containing metal catalyzer, thus makes reaction have efficient and high enantioselectivity.Shou Xin oxazoline metallic palladium title complex achieves certain catalytic effect in asymmetric catalysis field in recent years.
Reference:
1.Synthesisofopticallyactivebis(2-oxazolines):crystalstructureofa1,2-bis(2-oxazolinyl)benzene·zincchloridecomplexChemischeBerichte(1991),124,(5),1173-80.
2.Novelchiralbisoxazolineligandswithabiphenylbackbone:preparation,complexation,andapplicationinasymmetriccatalyticreactionsByImai,Yoshitane;Zhang,Wanbin;Kida,Toshiyuki;Nakatsuji,Yohji;Ikeda,Isao,JournalofOrganicChemistry(2000),65(11),3326-3333.
3.Rhodium(III)andRhodium(II)ComplexesofNovelBis(oxazoline)PincerLigandsGerisch,Michael;Krumper,JenniferR.;Bergman,RobertG.;Tilley,T.Don,Organometallics(2003),22(1),47-58。
three, summary of the invention
The present invention aims to provide a kind of Pd-N a metal-organic complex to be applied to catalytic field, and technical problem to be solved is selected neighbour and selected corresponding raw material and set up corresponding method synthesis of chiral catalyzer.
Chirality palladium nitrogen complex alleged by the present invention is by the title complex shown in following chemical formula (I):
Chemical name: [1,2-(4R)-dibenzyl-2-oxazolinyl benzene] palladium chloride complex, is called for short title complex (I).
The synthetic method of this chiral coordination compound (I) comprises reaction, abstraction and purification, it is characterized in that by adjacent dicyanobenzenes 5.5782g and D-phenylalaninol 19.2782g under anhydrous and oxygen-free condition and the anhydrous ZnCl of catalyzer 2(23.8mol%) back flow reaction 60 hours in chlorobenzene solvent, is then separated, purifying, and namely reaction sloughs chlorobenzene after terminating, with chloroform extraction after being dissolved in water, with column chromatography purification after extraction phase precipitation; By sherwood oil and methylene dichloride (4:1) drip washing, column chromatography for separation, volatilize to obtain Pei Ti oxazoline naturally; Again by chirality Pei Ti oxazoline and Palladous chloride according to 1:1.0 mol ratio back flow reaction 48 hours in chlorobenzene solvent, chlorobenzene is sloughed after reaction terminates, obtain red brown solid, after adding trichloromethane and ethanolic soln filtration, filtrate of naturally volatilizing obtains Hong He Se oxazoline palladium complex monocrystalline.
This title complex shows certain catalytic performance in the Henle reaction and allyl group alkylated reaction of phenyl aldehyde, and its transformation efficiency reaches 85% and 68% respectively.
four, accompanying drawing explanation
Fig. 1 is the single crystal diffraction figure of title complex (I).
five, embodiment
(1) preparation of chiral coordination compound (I)
1. the preparation of [1,2-(4R)-dibenzyl-2-oxazolinyl] benzene
ZnCl 21.7109g (12.55mmol), 40ml chlorobenzene, 1,2-dicyanobenzenes 6.5031g (50.7mmol), D-benzene glycinol 21.4037g, at high temperature reflux mixture 24h, stopped reaction, reduce pressure to remove desolventizing,, will remain in 100mL two-mouth bottle, under anhydrous and oxygen-free condition, add anhydride water dissolution, and use CHCl 3(20mLx2) extract, organic phase anhydrous sodium sulfate drying, rotate except desolventizing, by thick product sherwood oil/methylene dichloride (4:1) column chromatography, obtain pale green viscous shape liquid yield 43%; Yellow liquid, [a] 5 d=+25.6o (c=0.349, CH 2cl 2); 1hNMR (500MHz, CDCl 3, 27 DEG C), δ (ppm)=7.71 ~ 7.74 (m, 2H), 7.41 ~ 7.44 (m, 2H), 7.16 ~ 7.30 (m, 10H), 4.57 ~ 4.63 (m, 2H), 4.34 ~ 4.40 (t, J=5.1Hz, 2H), 4.13 ~ 4.18 (t, 2H). 13cNMR41.2367.89,72.03,32.81,126.27,126.39,128.24,128.32,128.45,129.06,129.20,129.20,129.61,129.83,130.19,137.83,163.92.IR:3061,3027,2924,2895,1710,1650,1602,1494,1471,1452,1356,1354,1312,1288,1288,1252,1091,1053,1053,1031,965,918,752,702.HRMS (EI): m/z (%): calcdforC 26h 24n 2o 2: 396.1838; Found:396.1837.
dibenzyl-2-oxazolinyl benzene] preparation of palladium chloride complex
In 100mL two-mouth bottle, under anhydrous and oxygen-free condition, add Palladous chloride 0.4233g (23.7mmol), 1,2-(4R)-dibenzyl-2-oxazolinyl benzene 0.9432g (2.38mmol), mixture at high temperature refluxes 48h by chlorobenzene 30mL, stopped reaction, reduce pressure to remove desolventizing,, by residuum trichloromethane and dissolve with ethanol, naturally volatilize, obtain sorrel title complex and obtain crystal, productive rate 56%; M.p.:230-232 ° of C, [a] 5 d=-19.7o (c=0.0712, CH 3oH) ultimate analysis C 26h 24n 2cl 2o 2pd test value C:54.17%, H, 4.68%, N, 4.93%; Calculated value: C:54.42%, H, 4.22%, N, 4.88%; IR:3443,3067,2973,2920,1637,1628,1591,1504,1455,1439,1389,1320,1249,1209,1073,993,960,949,782,768,759,719,737.Title complex (I) crystal data is as follows:
Empirical formula C26H24Cl2N2O2Pd
Molecular weight 573.77
Temperature 133 (2) K
Wavelength 0.71073
Crystallographic system, Space group Monoclinic system, P2 (1) 2(1) 2(1)
Unit cell parameters a=7.956 (7) α=90 °.
b=12.5079(8)?β=90°
c=21.247(17)?γ=90°.
Volume 2327(3) A^3
Electric density 4,1.637Mg/m^3
Absorption correction parameter 1.054mm^-1
Number of electrons 1160 in unit cell
Crystallographic dimension 0.190x0.140x0.050mm
The scope 1.762to25.498 at Theta angle
Index capture range-the 9<=h<=9 of HKL ,-16<=k<14 ,-22<=l<=25
Collection/independent diffraction data 13413/4278 [R (int)=0.1970]
The data integrity degree 98.7% of theta=30.5
The method Multi Slice Mode of absorption correction
The transmitance 0.7456and0.2912 of minimax
The Matrix least square method of the method F^2 that refine uses
Number/the number of parameters 4278/0/299 of data number/use restriction
The method 1.029 that refine uses
The consistence factor R 1=0.0716 of point diffraction, wR2=0.1528
Identical factor R 1=0.1498, the wR2=0.1866 of observable diffraction
Absolute configuration parameter-0.01(7)
Maximum summit on difference Fourier figure and peak valley 1.610and-1.347e.A^-3
the typical bond distance's data of crystal:
Pd(1)-N(1)2.025(14)
Pd(1)-N(2)2.059(12)
Pd(1)-Cl(1)2.300(5)
Pd(1)-Cl(2)2.304(4)
N(1)-C(7)1.25(2)
N(1)-C(9)1.54(2)
N(2)-C(17)1.28(2)
N(2)-C(19)1.50(2)
O(1)-C(7)1.38(2)
O(1)-C(8)1.47(2)
O(2)-C(17)1.35(2)
O(2)-C(18)1.44(2)
C(1)-C(2)1.41(2)
C(1)-C(17)1.43(3)
C(1)-C(6)1.47(2)
C(2)-C(3)1.38(2)
C(2)-H(2)0.9500
C(3)-C(4)1.37(2)
C(3)-H(3)0.9500
C(4)-C(5)1.41(2)
C(4)-H(4)0.9500
C(5)-C(6)1.34(2)
C(5)-H(5)0.9500
C(6)-C(7)1.49(3)
C(8)-C(9)1.55(2)
C(8)-H(8A)0.9900
C(8)-H(8B)0.9900
C(9)-C(10)1.54(2)
C(9)-H(9)1.0000
C(10)-C(11)1.48(3)
C(10)-H(10A)0.9900
C(10)-H(10B)0.9900
C(11)-C(16)1.40(2)
C(11)-C(12)1.43(2)
C(12)-C(13)1.35(3)
C(12)-H(12)0.9500
C(13)-C(14)1.42(3)
C(13)-H(13)0.9500
C(14)-C(15)1.41(3)
C(14)-H(14)0.9500
C(15)-C(16)1.34(3)
C(15)-H(15)0.9500
C(16)-H(16)0.9500
C(18)-C(19)1.56(2)
C(18)-H(18A)0.9900
C(18)-H(18B)0.9900
C(19)-C(20)1.53(2)
C(19)-H(19)1.0000
C(20)-C(21)1.48(2)
C(20)-H(20A)0.9900
C(20)-H(20B)0.9900
C(21)-C(22)1.38(2)
C(21)-C(26)1.43(2)
C(22)-C(23)1.37(3)
C(22)-H(22)0.9500
C(23)-C(24)1.36(3)
C(23)-H(23)0.9500
C(24)-C(25)1.37(3)
C(24)-H(24)0.9500
C(25)-C(26)1.37(2)
C(25)-H(25)0.9500
C(26)-H(26)0.9500
the typical bond angle data of crystal:
N(1)-Pd(1)-N(2)88.2(5)
N(1)-Pd(1)-Cl(1)177.1(4)
N(2)-Pd(1)-Cl(1)89.4(4)
N(1)-Pd(1)-Cl(2)93.4(4)
N(2)-Pd(1)-Cl(2)175.9(4)
Cl(1)-Pd(1)-Cl(2)89.09(18)
C(7)-N(1)-C(9)108.7(14)
C(7)-N(1)-Pd(1)126.1(11)
C(9)-N(1)-Pd(1)125.1(11)
C(17)-N(2)-C(19)110.4(13)
C(17)-N(2)-Pd(1)124.5(13)
C(19)-N(2)-Pd(1)123.4(11)
C(7)-O(1)-C(8)104.5(14)
C(17)-O(2)-C(18)107.6(13)
C(2)-C(1)-C(17)120.3(16)
C(2)-C(1)-C(6)115.0(17)
C(17)-C(1)-C(6)124.5(16)
C(3)-C(2)-C(1)122.4(16)
C(3)-C(2)-H(2)118.8
C(1)-C(2)-H(2)118.8
C(4)-C(3)-C(2)120.9(17)
C(4)-C(3)-H(3)119.6
C(2)-C(3)-H(3)119.6
C(3)-C(4)-C(5)119.0(18)
C(3)-C(4)-H(4)120.5
C(5)-C(4)-H(4)120.5
C(6)-C(5)-C(4)121.0(17)
C(6)-C(5)-H(5)119.5
C(4)-C(5)-H(5)119.5
C(5)-C(6)-C(1)121.6(16)
C(5)-C(6)-C(7)117.0(16)
C(1)-C(6)-C(7)121.3(17)
N(1)-C(7)-O(1)117.3(16)
N(1)-C(7)-C(6)131.8(16)
O(1)-C(7)-C(6)110.9(16)
O(1)-C(8)-C(9)105.3(13)
O(1)-C(8)-H(8A)110.7
C(9)-C(8)-H(8A)110.7
O(1)-C(8)-H(8B)110.7
C(9)-C(8)-H(8B)110.7
H(8A)-C(8)-H(8B)108.8
C(10)-C(9)-N(1)111.8(13)
C(10)-C(9)-C(8)111.5(15)
N(1)-C(9)-C(8)98.7(13)
C(10)-C(9)-H(9)111.4
N(1)-C(9)-H(9)111.4
C(8)-C(9)-H(9)111.4
C(11)-C(10)-C(9)116.9(15)
C(11)-C(10)-H(10A)108.1
C(9)-C(10)-H(10A)108.1
C(11)-C(10)-H(10B)108.1
C(9)-C(10)-H(10B)108.1
H(10A)-C(10)-H(10B)107.3
C(16)-C(11)-C(12)116.5(18)
C(16)-C(11)-C(10)122.1(17)
C(12)-C(11)-C(10)121.5(16)
C(13)-C(12)-C(11)119.8(18)
C(13)-C(12)-H(12)120.1
C(11)-C(12)-H(12)120.1
C(12)-C(13)-C(14)122.8(18)
C(12)-C(13)-H(13)118.6
C(14)-C(13)-H(13)118.6
C(15)-C(14)-C(13)116.8(19)
C(15)-C(14)-H(14)121.6
C(13)-C(14)-H(14)121.6
C(16)-C(15)-C(14)120(2)
C(16)-C(15)-H(15)119.9
C(14)-C(15)-H(15)119.9
C(15)-C(16)-C(11)123.9(19)
C(15)-C(16)-H(16)118.0
C(11)-C(16)-H(16)118.0
N(2)-C(17)-O(2)115.4(16)
N(2)-C(17)-C(1)131.5(17)
O(2)-C(17)-C(1)113.0(15)
O(2)-C(18)-C(19)105.5(14)
O(2)-C(18)-H(18A)110.6
C(19)-C(18)-H(18A)110.6
O(2)-C(18)-H(18B)110.6
C(19)-C(18)-H(18B)110.6
H(18A)-C(18)-H(18B)108.8
N(2)-C(19)-C(20)110.4(14)
N(2)-C(19)-C(18)100.2(14)
C(20)-C(19)-C(18)111.9(14)
N(2)-C(19)-H(19)111.3
C(20)-C(19)-H(19)111.3
C(18)-C(19)-H(19)111.3
C(21)-C(20)-C(19)116.5(13)
C(21)-C(20)-H(20A)108.2
C(19)-C(20)-H(20A)108.2
C(21)-C(20)-H(20B)108.2
C(19)-C(20)-H(20B)108.2
H(20A)-C(20)-H(20B)107.3
C(22)-C(21)-C(26)117.4(16)
C(22)-C(21)-C(20)121.9(17)
C(26)-C(21)-C(20)120.7(16)
C(23)-C(22)-C(21)122.9(18)
C(23)-C(22)-H(22)118.6
C(21)-C(22)-H(22)118.6
C(24)-C(23)-C(22)118.6(18)
C(24)-C(23)-H(23)120.7
C(22)-C(23)-H(23)120.7
C(23)-C(24)-C(25)120.8(18)
C(23)-C(24)-H(24)119.6
C(25)-C(24)-H(24)119.6
C(26)-C(25)-C(24)121.5(18)
C(26)-C(25)-H(25)119.2
C(24)-C(25)-H(25)119.2
C(25)-C(26)-C(21)118.9(17)
C(25)-C(26)-H(26)120.6
C(21)-C(26)-H(26)120.6
(2), Henle reaction application
Get 0.10mmol title complex (I) (catalytic amount is 10%) in the little flask of 25mL, add the tetrahydrofuran solution of 2 milliliters, then, in above-mentioned solution, add the phenyl aldehyde of 0.1mL and the Nitromethane 99Min. of 0.5mL, stirring at normal temperature, react 48 hours, with sherwood oil/eluent methylene chloride, carry out column chromatography, productive rate 85%. 1hNMR (300MHz, CDCl 3).
(3) allyl group alkylated reaction application
The title complex I(catalytic amount of getting 0.20mmol is 20%) in the little flask of 25mL, add the dichloromethane solution of 2 milliliters, then, the phenyl aldehyde of 0.1mL and the allyl trimethyl silane of 0.3mL is added in above-mentioned solution, stirring at normal temperature, react after 48 hours, carry out nmr analysis, transformation efficiency: 68%; 1hNMR (300MHz, CDCl 3) 7.27 ~ 7.33 (m, 5H, Ar-H), 5.79 ~ 5.80 (m, 1H), 5.12 ~ 5.17 (m, 2H ,-CH 2), 4.71(d, J=5Hz, 1H), 2.49 ~ 2.50 (m, 2H), 2.28(s, 1H).
Under applicant's parallel condition, done the another two compounds II of similar this complex structure (I) and III catalysis Henle reaction and allyl group alkylated reaction, its catalytic effect is shown in following Application Example; Its structural formula is as follows:
IIIII
Henle reaction is applied
Get 0.10mmol title complex II and III(catalytic amount is 10%) in the little flask of 25mL, add the tetrahydrofuran solution of 2 milliliters, then, in above-mentioned solution, add the phenyl aldehyde of 0.1mL and the Nitromethane 99Min. of 0.5mL, stirring at normal temperature, react 48 hours, with sherwood oil/eluent methylene chloride, carry out column chromatography, productive rate is respectively 46%., and 58% 1hNMR (300MHz, CDCl 3), 8.00 (d, J=23Hz, 1H), 7.47 ~ 7.63 (m, 6H).
Allyl group alkylated reaction is applied
Title complex II and the III(catalytic amount of getting 0.20mmol are 20%) in the little flask of 25mL, add the dichloromethane solution of 2 milliliters, then, the phenyl aldehyde of 0.1mL and the allyl trimethyl silane of 0.3mL is added in above-mentioned solution, stirring at normal temperature, reacts after 48 hours, carries out nmr analysis, transformation efficiency is respectively: 28%, and 36%; 1hNMR (300MHz, CDCl 3) 7.27 ~ 7.33 (m, 5H, Ar-H), 5.79 ~ 5.80 (m, 1H), 5.12 ~ 5.17 (m, 2H ,-CH 2), 4.71(d, J=5Hz, 1H), 2.49 ~ 2.50 (m, 2H), 2.28(s, 1H).

Claims (2)

1. a chiral oxazoline palladium complex, its chemical formula is as follows:
(Ⅰ)
2. the synthetic method of title complex according to claim 1 (I), comprises reaction, abstraction and purification, it is characterized in that by adjacent dicyanobenzenes 5.5782g and D-phenylalaninol 19.2782g under anhydrous and oxygen-free condition and the anhydrous ZnCl of catalyzer 2(23.8mol%) back flow reaction 60 hours in chlorobenzene solvent, is then separated, purifying, and namely reaction sloughs chlorobenzene after terminating, with chloroform extraction after being dissolved in water, with column chromatography purification after extraction phase precipitation; Be 4:1 drip washing by volume with sherwood oil and methylene dichloride, column chromatography for separation, volatilize to obtain Pei Ti oxazoline naturally; Again by chirality Pei Ti oxazoline and Palladous chloride according to 1:1.0 mol ratio back flow reaction 48 hours in chlorobenzene solvent, chlorobenzene is sloughed after reaction terminates, obtain red brown solid, after adding trichloromethane and ethanolic soln filtration, filtrate of naturally volatilizing obtains Hong He Se oxazoline palladium complex monocrystalline.
CN201510636902.9A 2015-10-02 2015-10-02 Chiral oxazoline palladium coordination compound Pending CN105198935A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510636902.9A CN105198935A (en) 2015-10-02 2015-10-02 Chiral oxazoline palladium coordination compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510636902.9A CN105198935A (en) 2015-10-02 2015-10-02 Chiral oxazoline palladium coordination compound

Publications (1)

Publication Number Publication Date
CN105198935A true CN105198935A (en) 2015-12-30

Family

ID=54946924

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510636902.9A Pending CN105198935A (en) 2015-10-02 2015-10-02 Chiral oxazoline palladium coordination compound

Country Status (1)

Country Link
CN (1) CN105198935A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107163085A (en) * 2017-06-09 2017-09-15 合肥祥晨化工有限公司 A kind of preparation of chiral platinum complex crystal and purposes
CN107337652A (en) * 2017-07-05 2017-11-10 合肥祥晨化工有限公司 A kind of Chiral oxazoline cobalt complex and purposes
CN108727290A (en) * 2018-04-12 2018-11-02 合肥工业大学 A kind of chiral oxazoline palladium complex and purposes
CN110305167A (en) * 2019-06-18 2019-10-08 合肥工业大学 A kind of preparation and purposes of chirality platinum complex

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102127028A (en) * 2010-11-24 2011-07-20 罗梅 Chiral oxazoline and synthesis method thereof
CN104628788A (en) * 2015-02-11 2015-05-20 罗梅 Chiral oxazoline palladium complex and use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102127028A (en) * 2010-11-24 2011-07-20 罗梅 Chiral oxazoline and synthesis method thereof
CN104628788A (en) * 2015-02-11 2015-05-20 罗梅 Chiral oxazoline palladium complex and use thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ABDESLAM EL HATIMI等,: "Chiral bis(oxazoline) ligands. Synthesis of mono- and bi-metallic complexes of nickel and palladium", 《J. CHEM. SOC., DALTON TRANS.》 *
CARSTEN BOLM等,: "Synthesis of Optically Active Bis(2-oxazolines): Crystal Structure of a 1,2-Bis(2-oxazolinyl)benzene ZnC12 Complex", 《CHEM. BER.》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107163085A (en) * 2017-06-09 2017-09-15 合肥祥晨化工有限公司 A kind of preparation of chiral platinum complex crystal and purposes
CN107337652A (en) * 2017-07-05 2017-11-10 合肥祥晨化工有限公司 A kind of Chiral oxazoline cobalt complex and purposes
CN108727290A (en) * 2018-04-12 2018-11-02 合肥工业大学 A kind of chiral oxazoline palladium complex and purposes
CN110305167A (en) * 2019-06-18 2019-10-08 合肥工业大学 A kind of preparation and purposes of chirality platinum complex

Similar Documents

Publication Publication Date Title
CN105198935A (en) Chiral oxazoline palladium coordination compound
CN102225944B (en) Chiral zinc nitrogen complexes
CN104628788A (en) Chiral oxazoline palladium complex and use thereof
CN102010443B (en) Chiral phosphonous bis-amino-oxazoline copper complex and synthesis method thereof
CN104876970A (en) Chiral bisoxazoline palladium complex crystal and synthesis method thereof
CN103193808A (en) Chirality zinc complex
CN112724168B (en) Chiral pyridine derived N, B ligand, preparation method and application in iridium-catalyzed asymmetric boronation reaction
CN103232480B (en) Chiral zinc complex
CN103012447A (en) Chiral oxazoline zinc complex
CN103113174B (en) Preparation method of phenolic compounds
CN103012443B (en) Chiral zinc complex
CN103554023B (en) The synthetic method of acridine derivatives and the polycyclic acridine derivative of synthesis
CN101693642B (en) Method for synthesizing 1,2-diphenylethylene compounds
CN104496929A (en) Chiral zinc complex crystal containing chloroform crystals and application of chiral zinc complex crystal
CN102153571B (en) Chirality zinc-nitrogen coordination compound
CN103570765B (en) Chiral oxazoline manganese complex crystal and synthetic method thereof
CN102633738A (en) Chiral zinc complex
CN103145742B (en) Chiral oxazoline zinc complex
CN103641787A (en) Chiral oxazolinyl cobalt complex and synthesis method thereof
CN103641788B (en) Synthesis method of chiral 2-carbonyl oxazoline
CN104004005B (en) A kind of paramorphism chirality zinc-nitrogen coordination compound
CN102875416B (en) Chiral compound
CN101537373B (en) Axial chiral binaphthyl-containing spirocyclic phosphonium salt phase transfer catalyst and preparation method thereof
CN103012445B (en) A kind of chiral zinc nitrogen complexes
CN103588597A (en) Method of preparing biaryl compounds in pure water

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20151230

WD01 Invention patent application deemed withdrawn after publication